About Us
Chongqing Pharscin Pharmaceutical Co., Ltd. (Stock Code: 002907.SZ), founded in 1996, is a national high‑tech, integrated pharmaceutical enterprise focused on R&D, manufacturing and commercialization.

Adhering to “Science‑led, Innovation‑driven”, Pharscin is committed to developing reliable medicines for global health and building a trusted international pharmaceutical brand.

Years Of Establishment

Patents
Employees
Innovative Drug R&D Pipelines
Drug Approval Numbers
+
+
+
Advance Internationalization 
Development History
1996
Phase I Pharma Plant Achieves NMPA GMP Certification
2017
Engaged in  R＆D of innovative drug—Pharscin US Inc.
2021
The facility passed the FDA cGMP inspection with zero Form 483s.
2025
Foundation of Pharscin
2002
Listed on the SESE Main board
2019
Phase Ⅴ China GMP approved 5G Digital Smart Factory
2023
Inovative drug ORIP-1001 entered
PhaseⅠclinical trial4 products approved in Singapore
Marketing HQ: No. 89, Middle Section of Huangshan Avenue, Liangjiang New Area, Chongqing Production Base: Industrial Park, Rongchang District, Chongqing
Chongqing Public Security Filing Number：50019002500856
TEL:029-67622999

FAX:023-67506555
Scan for more info